Polymerase Chain Reaction (PCR) Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Polymerase Chain Reaction (PCR) Market Size By 2025?
The scale of the Polymerase Chain Reaction (PCR) market has experienced significant expansion in the recent past. The market, valued at $11.42 billion in 2024, is projected to escalate to $12.67 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 11.0%. Factors contributing to this growth during the historic period include a surge in the number of research facilities, a rise in the prevalence of chronic and infectious diseases, an increased incidence of genetic and chronic disorders, population growth, and an aging population.

How Big Is the Polymerase Chain Reaction (PCR) Market Size Expected to Grow by 2029?
The market size of the polymerase chain reaction (PCR) is projected to undergo considerable expansion in the forthcoming years, with projections indicating a growth to $18.97 billion in 2029, at a compound annual growth rate (CAGR) of 10.6%. This forecasted growth in the PCR market can be ascribed to mounting concerns about food safety, greater demand for safe and high-quality food commodities, escalating demand for molecular diagnostics, and personalized medicine needs, along with a focus on digital polymerase chain reaction (dPCR). Significant trends forecasted for this period encompass real-time polymerase chain reaction, the advancements in DNA sequencing technologies and diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of superior molecular diagnostic solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Which Key Market Drivers Powering Polymerase Chain Reaction (PCR) Market Expansion and Growth?
The growth of the polymerase chain reaction (PCR) market is anticipated to be driven by the burgeoning requirement for personalized medicine. Personalized, or precision, medicine means a healthcare approach that individualizes health decisions, proceedings, strategies, and treatments based on each patient's unique attributes. The drive for personalized medicine is escalating due to advancements in data analytics, patient-specific treatment responses, and the ability to customize therapies according to individual genetic blueprints. Personalized medicine is enabled by PCR, which allows for the amplification and examination of particular genetic sequences, letting medical practitioners modify treatment strategies as per individual genetic outlines. For example, as reported by the US-based professional membership organization, the Personalized Medicine Coalition, in 2022, the approval of 12 new personalized medicines constituting around 34% of all freshly approved therapies, signifying a considerable rise from preceding years. Thus, the escalating need for personalized medicine is fueling the expansion of the polymerase chain reaction market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Polymerase Chain Reaction (PCR) Market?
Key players in the polymerase chain reaction market are creating real-time polymerase chain reaction testing kits to enhance precision, productivity, and user-friendliness in genetic analysis. The real-time polymerase chain reaction (RT-PCR), a lab-produced test kit, is used to magnify and measure specific DNA sequences in real-time. For example, Cepheid, a molecular diagnostics firm based in the US, introduced the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This is an FDA-approved multiplex PCR test capable of identifying DNA from organisms linked with three separate vaginal infections - bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis from a single vaginal swab sample. By offering real-time tracking, quantification, and elevated sensitivity and specificity, it enhances the traditional polymerase chain reaction techniques, making it an essential asset in molecular biology and clinical diagnostics.

What Are the Emerging Segments in the Polymerase Chain Reaction (PCR) Market?
The polymerase chain reaction (PCR) market covered in this report is segmented -

1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization

Subsegments:
1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr
2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15638&type=smp

Who Are the Global Leaders in the Polymerase Chain Reaction (PCR) Market?
Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

Which are the Top Profitable Regional Markets for the Polymerase Chain Reaction (PCR) Industry?
North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15638

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.